Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...

HIV response. Experts are suggesting a projected 24% decrease in HIV funding over the next year in the context of reductions ...

Sloan’s attorneys filed a lawsuit against LMDC and Louisville Metro Government seeking damages for physical injuries, ...

What is the history of the AIDS epidemic, when did treatment become widely available, and what are the current goals for ending this epidemic?

The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world.

These employees will reenter the National Center for Environmental Health, the Global Health Center, and more agencies diminished by federal layoffs.